Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
29.3%
% of XPH's 40 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 11.8% | 4.6% | 4.6% | |
MERCK & CO. INC. | 5.9% | 4.6% | 4.6% | |
PFIZER INC | 4.5% | 4.6% | 4.5% | |
JOHNSON & JOHNSON | 6.6% | 4.4% | 4.4% | |
BRISTOL-MYERS SQUIBB CO | 4.4% | 4.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
NOVO-NORDISK A/S-SPONS ADR | 9.6% | |
ELI LILLY & CO | 7.2% | |
ABBVIE INC | 6.0% | |
ASTRAZENECA PLC-SPONS ADR | 5.1% | |
NOVARTIS AG-ADR | 4.7% | |
AMERISOURCEBERGEN CORP | 4.7% | |
MCKESSON CORP | 4.6% | |
SANOFI-AVENTIS-ADR | 4.5% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.4% |
PPH Underweight Relative to XPH
AXSOME THERAPEUTICS, INC. | -5.0% | |
INTRA-CELLULAR THERAPIES INC | -4.7% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
PERRIGO CO | -4.0% | |
ORGANON & CO. | -3.8% | |
CYMABAY THERAPEUTICS, INC. | -3.7% | |
JAZZ PHARMACEUTICALS PLC | -3.6% | |
CATALENT INC | -3.6% | |
ELANCO ANIMAL HEALTH, INC. | -3.5% | |
CORCEPT THERAPEUTICS INC | -3.4% |